Is nasal high-flow therapy of value in hypercapnic COPD?

Trial pits the device against non-invasive ventilation
Medicom Staff writer
doctors recording information on clipboard and tablet

AusDoc brings you the latest news from the European Respiratory Society Congress 2020.

Patients with chronic hypercapnic COPD who reject non-invasive ventilation might do as well with nasal high-flow therapy, a study suggests.

The new approach to oxygen delivery might be especially useful for patients who will not tolerate a face mask, the authors say.

German researchers presented the results of a study of 102 patients with the condition to the European Respiratory Society’s 2020 (ERS 2020) international virtual congress.